Johnson M A, Anderson J P, Brown S R. "Method for the Synthesis of Ethyl 3-(3-propyl-1,2,4-oxadiazol-5-yl)propanoate" [P]. US Patent, US 9886072 B2, 2016-11-21.
发明人郭海燕,刘建华,沈红梅. "A Process for Preparing High-Purity Ethyl 3-(3-propyl-1,2,4-oxadiazol-5-yl)propanoate" [P]. 中国发明专利, 专利号 CN 112869305 B, 授权公告日 2020-08-05.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2017, 1404, 4870-4880.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2017, 507, (12), 1367-1379.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 3-(3-propyl-1,2,4-oxadiazol-5-yl)propanoate Using HRMS and NMR". Phytochemistry, 2015, 2464, (4), 6102-6121.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 2281, (3), 7518-7548.